News tagged with 'Diana Levine'

The lawsuit against Cedars-Sinai Medical Center by actor, Dennis Quaid and his wife has settled for $750,000.  Their newborn twins received an overdose of the drug heparin and they bled out nearly dying. The twins have since recovered, but the Quaids have formed a foundation to inform the public about the "conspiracy of silence" of medical errors that kill 100,000 a year. 

Access Denied?: The Fight for Corporate Accountability - a new documentary about the real human faces of federal pre-emption, and how it takes a toll on those already sick and injured. Alliance for Justice is premiering the film to the nation, Tuesday, November 18th and providing viewers with an opportunity to have an on-line chat with the woman's who is the face of federal pre-emption, Diana Levine. 

When Diana Levine turned 63 recently, her daughter made her a birthday card drawing her as Diana the Huntress of Greek mythology, except without a right arm. The character pulls back a bow string ready to strike the Wyeth monster. In her case before the U.S. Supreme Court Monday, consumers should question whether they can believe a drug's label?

The Medical Device Safety Act of 2008 attempts to overturn the Riegel decision concerning the immunity of medical device makers who harm the public. Alliance for Justices' Simon Heller, who was at the U.S. Supreme Court today, says the Diana  Levine case may very well end up being addressed by Congress.  

The Diana Levine case went before the U.S. Supreme Court this morning and Simon Heller of the Alliance for Justice was there.... He talks to IB News.

Before the U.S. Supreme Court today- the issue of Diana Levine, which pits an injured consumer against drug giant, Wyeth. The outcome will set the stage for whether a federal standard can trump any state lawsuits. The outcome affects all consumers of products, drugs, and medical devices.  

With the help of internal FDA emails, citizens can read how pre-emption language was inserted into FDA rules to benefit big business, despite objections, while headed by an industry lawyer who took the revolving door back into industry.  Monday, the U.S. Supreme Court will decide on a case shaped by pre-emption, the outcome of which potentially affects the health and safety of all citizens for years to come.  

Three decades ago, as Diana Levine's career as a children's music producer and performer was just starting to take off, ultraconservatives and drug companies had their sights set on a different kind of breakthrough...

Key FDA career officials strongly objected to Bush Administration drug labeling regulations that would preempt state liability lawsuits, according to a new report by the Committee on Oversight and Government Reform.

Chantix, the smoking cessation drug, and heparin top the list of the drugs most likely to cause death and injury as compiled by this watchdog group.  They represent just a tip of the iceberg.

As the Bush administration winds down, there is a last minute push toward adding pre-emptive language to agencies that oversee everyday products, which essentially block consumer product liability lawsuits.  

Upon returning for a new term on Monday, the Supreme Court justices weighed a complicated legal battle, whether state laws can be used to challenge deceptive advertising of “light” cigarettes. Altria Group v. Good is the latest case in a growing debate over preemption.

Consumers are increasingly wary about what FDA approval means in light of food and product recalls, unsafe drugs and novel new foods that go virtually unregulated. Yet "FDA approved" is increasingly carrying the weight of the law of the land, stripping you of your right to go to court.  

What Does FDA Approval Mean?  While that promise has traditionally meant an assurance of safety, the FDA is having a difficult time keeping up with its responsibilities. At the same time, "FDA approved" is increasingly being used to strip consumers of their right to take defective products to court.

Diana Levine's case to go before the US Supreme Court in a few weeks is on the front page of the New York Times and may raise the conversation about the trend of federal pre-emption.  Comments that follow the story show the sharp divisions in this country over corporate rights versus the public interest.